Electrocardiographic parameters of repolarization and heart rate variability in prostate cancer patients with drug induced hypogonadism

Electrocardiographic parameters of repolarization and heart rate variability in prostate cancer patients with drug induced hypogonadism

We aimed to assess the electrocardiographic changes related to arrhythmic risk in advanced prostate cancer patients with drug induced hypogonadism. The dataset contains raw clinical and ECG data from 35 patients treated with degarelix plus enzalutamide (treatment group A, 26 patients) or without enz...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Gheorghe, Andrei Cristian Dan
Format: Dataset
Sprache:eng
Schlagworte:
Arrhythmia
Cardiology
Electrocardiography
Heart Rate Variability
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Gheorghe, Andrei Cristian Dan
description We aimed to assess the electrocardiographic changes related to arrhythmic risk in advanced prostate cancer patients with drug induced hypogonadism. The dataset contains raw clinical and ECG data from 35 patients treated with degarelix plus enzalutamide (treatment group A, 26 patients) or without enzalutamide (treatment group B, 9 patients) observed at the beginning (M0) and after 6 months of therapy (M1). A subset of 25 patients of the same group performed also Holter ECG study with assessment of heart rate variability and occurrence of ventricular premature beats. Corrected QT interval (QTc), QT dispersion (QTd), J-Tpeak interval (JPp), Tpeak-Tend interval (Tpe), Tpe/QT ratio (Tpe/QT), Tpeak-Tend dispersion (Tped) and the index of cardio-electrophysiological balance (iCEB) were measured on ECG tracings. Heart rate correction was made using Fridericia formula. Heart rate variability was assessed in both time and frequency domains.
doi_str_mv 10.17632/yjsp52k9sc.3
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_17632_yjsp52k9sc_3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_17632_yjsp52k9sc_3</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_17632_yjsp52k9sc_33</originalsourceid><addsrcrecordid>eNqVjz2OwjAQhd1QINiSfi7AT4gWRI1AHIDemrWHZJbEtsYDKFyAaxMQ0tZbPem9T5_0jJkUi1mxXpXLefeb0_fyvMluVg7NY9eQU4kOxXOsBFPNDhIKtqQkGeIJhFJsUPiOyjEABg81oSgIKsG1X_CHG9YOOECSmPXVOwyOpFcpU9AMN9YavFyqnvIXR72kS7GKAT3ndmwGJ2wyfX1yZKb73XF7mHpUdKxkk3CL0tliYd9H7N8RW5b_5Z-UvV1q</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Electrocardiographic parameters of repolarization and heart rate variability in prostate cancer patients with drug induced hypogonadism</title><source>DataCite</source><creator>Gheorghe, Andrei Cristian Dan</creator><creatorcontrib>Gheorghe, Andrei Cristian Dan</creatorcontrib><description>We aimed to assess the electrocardiographic changes related to arrhythmic risk in advanced prostate cancer patients with drug induced hypogonadism. The dataset contains raw clinical and ECG data from 35 patients treated with degarelix plus enzalutamide (treatment group A, 26 patients) or without enzalutamide (treatment group B, 9 patients) observed at the beginning (M0) and after 6 months of therapy (M1). A subset of 25 patients of the same group performed also Holter ECG study with assessment of heart rate variability and occurrence of ventricular premature beats. Corrected QT interval (QTc), QT dispersion (QTd), J-Tpeak interval (JPp), Tpeak-Tend interval (Tpe), Tpe/QT ratio (Tpe/QT), Tpeak-Tend dispersion (Tped) and the index of cardio-electrophysiological balance (iCEB) were measured on ECG tracings. Heart rate correction was made using Fridericia formula. Heart rate variability was assessed in both time and frequency domains.</description><identifier>DOI: 10.17632/yjsp52k9sc.3</identifier><language>eng</language><publisher>Mendeley</publisher><subject>Arrhythmia ; Cardiology ; Electrocardiography ; Heart Rate Variability</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1887</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.17632/yjsp52k9sc.3$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gheorghe, Andrei Cristian Dan</creatorcontrib><title>Electrocardiographic parameters of repolarization and heart rate variability in prostate cancer patients with drug induced hypogonadism</title><description>We aimed to assess the electrocardiographic changes related to arrhythmic risk in advanced prostate cancer patients with drug induced hypogonadism. The dataset contains raw clinical and ECG data from 35 patients treated with degarelix plus enzalutamide (treatment group A, 26 patients) or without enzalutamide (treatment group B, 9 patients) observed at the beginning (M0) and after 6 months of therapy (M1). A subset of 25 patients of the same group performed also Holter ECG study with assessment of heart rate variability and occurrence of ventricular premature beats. Corrected QT interval (QTc), QT dispersion (QTd), J-Tpeak interval (JPp), Tpeak-Tend interval (Tpe), Tpe/QT ratio (Tpe/QT), Tpeak-Tend dispersion (Tped) and the index of cardio-electrophysiological balance (iCEB) were measured on ECG tracings. Heart rate correction was made using Fridericia formula. Heart rate variability was assessed in both time and frequency domains.</description><subject>Arrhythmia</subject><subject>Cardiology</subject><subject>Electrocardiography</subject><subject>Heart Rate Variability</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2020</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNqVjz2OwjAQhd1QINiSfi7AT4gWRI1AHIDemrWHZJbEtsYDKFyAaxMQ0tZbPem9T5_0jJkUi1mxXpXLefeb0_fyvMluVg7NY9eQU4kOxXOsBFPNDhIKtqQkGeIJhFJsUPiOyjEABg81oSgIKsG1X_CHG9YOOECSmPXVOwyOpFcpU9AMN9YavFyqnvIXR72kS7GKAT3ndmwGJ2wyfX1yZKb73XF7mHpUdKxkk3CL0tliYd9H7N8RW5b_5Z-UvV1q</recordid><startdate>20200109</startdate><enddate>20200109</enddate><creator>Gheorghe, Andrei Cristian Dan</creator><general>Mendeley</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20200109</creationdate><title>Electrocardiographic parameters of repolarization and heart rate variability in prostate cancer patients with drug induced hypogonadism</title><author>Gheorghe, Andrei Cristian Dan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_17632_yjsp52k9sc_33</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Arrhythmia</topic><topic>Cardiology</topic><topic>Electrocardiography</topic><topic>Heart Rate Variability</topic><toplevel>online_resources</toplevel><creatorcontrib>Gheorghe, Andrei Cristian Dan</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gheorghe, Andrei Cristian Dan</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Electrocardiographic parameters of repolarization and heart rate variability in prostate cancer patients with drug induced hypogonadism</title><date>2020-01-09</date><risdate>2020</risdate><abstract>We aimed to assess the electrocardiographic changes related to arrhythmic risk in advanced prostate cancer patients with drug induced hypogonadism. The dataset contains raw clinical and ECG data from 35 patients treated with degarelix plus enzalutamide (treatment group A, 26 patients) or without enzalutamide (treatment group B, 9 patients) observed at the beginning (M0) and after 6 months of therapy (M1). A subset of 25 patients of the same group performed also Holter ECG study with assessment of heart rate variability and occurrence of ventricular premature beats. Corrected QT interval (QTc), QT dispersion (QTd), J-Tpeak interval (JPp), Tpeak-Tend interval (Tpe), Tpe/QT ratio (Tpe/QT), Tpeak-Tend dispersion (Tped) and the index of cardio-electrophysiological balance (iCEB) were measured on ECG tracings. Heart rate correction was made using Fridericia formula. Heart rate variability was assessed in both time and frequency domains.</abstract><pub>Mendeley</pub><doi>10.17632/yjsp52k9sc.3</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.17632/yjsp52k9sc.3
ispartof
issn
language eng
recordid cdi_datacite_primary_10_17632_yjsp52k9sc_3
source DataCite
subjects Arrhythmia
Cardiology
Electrocardiography
Heart Rate Variability
title Electrocardiographic parameters of repolarization and heart rate variability in prostate cancer patients with drug induced hypogonadism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T13%3A27%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Gheorghe,%20Andrei%20Cristian%20Dan&rft.date=2020-01-09&rft_id=info:doi/10.17632/yjsp52k9sc.3&rft_dat=%3Cdatacite_PQ8%3E10_17632_yjsp52k9sc_3%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true